HAEMONETICS CORP Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Haemonetics Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q1 2024.
  • Haemonetics Corp Operating Lease, Right-of-Use Asset for the quarter ending March 30, 2024 was $55.3M, a 3.47% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $55.3M +$1.86M +3.47% Mar 30, 2024 10-K 2024-05-20
Q1 2023 $53.4M +$664K +1.26% Apr 1, 2023 10-K 2024-05-20
Q1 2022 $52.7M -$7.11M -11.9% Apr 2, 2022 10-K 2023-05-22
Q1 2021 $59.9M +$7.62M +14.6% Apr 3, 2021 10-K 2022-05-25
Q1 2020 $52.2M Mar 28, 2020 10-K 2021-05-26
Q4 2019 $54.2M Dec 28, 2019 10-Q 2020-02-04
Q3 2019 $19.4M Sep 28, 2019 10-Q 2019-11-01
Q2 2019 $21.2M Jun 29, 2019 10-Q 2019-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.